cpg 10104
Biologicalexperimental
Clinical trial activity
3 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2014 (NCT02143518)
Timeline
Indications
Studied for
Mechanism of action
- Toll-like receptor 9AGONIST
TLR9 agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- cpg10104
- cpg 10104
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03373214 | Phase 1 | Feb 1, 2018 | Baylor University, Centre de Recherche Médicale de Lambaréné, George Washington University, Leiden University, University of Amsterdam |
| NCT03172975 | Phase 2 | Jul 15, 2017 | Baylor University, George Washington University, National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT02143518 | Phase 1 | Oct 1, 2014 | Baylor University, George Washington University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Baylor University | Academic/Hospital | 3 | 3 | 2 | 2014 |
| George Washington University | Academic/Hospital | 3 | 0 | 2 | 2014 |
| Centre de Recherche Médicale de Lambaréné | Academic/Hospital | 1 | 0 | 1 | 2018 |
| Leiden University | Academic/Hospital | 1 | 0 | 1 | 2018 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 1 | 0 | 1 | 2017 |
| University of Amsterdam | Academic/Hospital | 1 | 0 | 1 | 2018 |
6 organizations
Page 1 / 1